Versant Venture Capital III L.P. 13D/13G Filings for Flexion Therapeutics, Inc. (FLXN)

Versant Venture Capital III L.P. 13D and 13G filings for Flexion Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2021-01-25
5:57 pm
Sale		 2021-01-15 13D Flexion Therapeutics, Inc.
FLXN		 Versant Venture Capital III L.P. 1,388,683
2.800%		 -2,550,409decrease
(-64.75%)		 Filing